LADUSOR Trademark

Trademark Overview

On Thursday, August 2, 2012, a trademark application was filed for LADUSOR with the United States Patent and Trademark Office. The USPTO has given the LADUSOR trademark a serial number of 85694169. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 11, 2022. This trademark is owned by Sunesis Pharmaceuticals, Inc.. The LADUSOR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of tumors, cancers, hematological disorders and hematological malignancies
ladusor

General Information

Serial Number85694169
Word MarkLADUSOR
Filing DateThursday, August 2, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 11, 2022
Registration Number4946457
Registration DateTuesday, April 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2013

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of tumors, cancers, hematological disorders and hematological malignancies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 11, 2022
Primary Code005
First Use Anywhere DateFriday, February 26, 2016
First Use In Commerce DateFriday, February 26, 2016

Trademark Owner History

Party NameSunesis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSunesis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSunesis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, November 11, 2022CANCELLED SEC. 8 (6-YR)
Monday, April 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 26, 2016REGISTERED-PRINCIPAL REGISTER
Friday, March 25, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 24, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 4, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, February 29, 2016USE AMENDMENT FILED
Monday, February 29, 2016TEAS STATEMENT OF USE RECEIVED
Thursday, July 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 22, 2015SOU EXTENSION 5 GRANTED
Friday, July 17, 2015SOU EXTENSION 5 FILED
Friday, July 17, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, February 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 24, 2015SOU EXTENSION 4 GRANTED
Friday, February 20, 2015SOU EXTENSION 4 FILED
Friday, February 20, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, September 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 2, 2014SOU EXTENSION 3 GRANTED
Tuesday, August 26, 2014SOU EXTENSION 3 FILED
Tuesday, August 26, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, March 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 11, 2014SOU EXTENSION 2 GRANTED
Friday, February 28, 2014SOU EXTENSION 2 FILED
Friday, February 28, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, July 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 23, 2013SOU EXTENSION 1 GRANTED
Friday, June 21, 2013SOU EXTENSION 1 FILED
Tuesday, July 23, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 21, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2012ASSIGNED TO EXAMINER
Monday, August 13, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 6, 2012NEW APPLICATION ENTERED

Related Keywords

ladusor hematological disorders malignancies cancers tumors preparations treatment pharmaceutical